Therosteon

Therosteon is an early stage biotechnology company focusing on therapies and biomarkers for bone diseases. The Company was spun-off the Erasmus Medical Center in 2008 and is based on a validated technology platform –OsteoBLAST- developed in the laboratory of its scientific founder Professor Hans van Leeuwen). The technology platform has been validated through various industrial collaborations. Further this platform has delivered new therapeutic drug targets, was used to identify drug-leads and will be used to further develop pharmaceutical compounds.

The Company received a worldwide exclusive license to all IP that was generated in the department Internal Medicine at the Erasmus University in the field of bone diseases

Therosteon is located in incubator facilities of the Erasmus Medical Center in Rotterdam and collaborates closely with academic group of its scientific founder Prof. Hans van Leeuwen.

Contact Details: ‘s-Gravendijkwal 230, Rm 1914 Rotterdam 3015 CE The Netherlands Tel: 31 620 543 382 Fax: Email: WWW: www.therosteon.com/

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 180 times since April 2007, the link to the organisation's website has been followed 57 times

Recent Search Terms used to find this page: hans van leeuwen rotterdam | therosteon september 2009 | therosteon | .

Search for more companies in Rotterdam

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Therosteon